Rosiglitazone-induced weight gain
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 18 Oct 2016 Status changed from recruiting to discontinued due to published data on Rosiglitazone.
- 19 Nov 2006 New trial record.